We found that the A3 receptor expressed in microdissected isolated Af-Art and the mRNA levels of A3 receptor were 59% of A1. In the isolated microperfused Af-Art, A3 receptor agonist IB-MECA did not have a constrictive effect. Activation of A3 receptor dilated the preconstricted Af-Art by norepinephrine and blunted the vasoconstrictive effect of both adenosine A1 receptor activation and ANG II on the Af-Art, respectively. Selective A 2 receptor antagonist (both A2A and A2B) had no effect on A3 receptor agonist-induced vasodilation, indicating that the dilatory effect of A3 receptor activation is not mediated by activation of A2 receptor. We conclude that the A3 receptor is expressed in the Af-Art, and activation of the A3 receptor dilates the Af-Art.
ADENOSINE IS AN ENDOGENOUS adenine nucleoside that is formed by the hydrolysis of ATP. Cellular signaling by adenosine occurs through following receptor subtypes: A 1 , A 2 , and A 3 . The adenosine A 2 receptor (A 2 R) family consists of two subtypes, A 2A and A 2B (36) . All receptors of adenosine have been found in the kidney (1, 16, 20, 37, 41) . Adenosine has been suggested as a mediator (via A 1 receptor signaling) and a modulator (via A 2 receptor) of renal autoregulation (2, 4, 5, 15, 28, 32, 34, 36) . In the renal vasculature, adenosine elicits biphasic effects with vasoconstriction via A 1 receptors (A 1 R) at a lower concentration and vasodilation via A 2 R as the concentration of adenosine increases (14, 27, 33) .
Adenosine A 3 receptor (A 3 R) is first found from the rat striatum (40) , and it is highly expressed in the lung and liver in humans (22, 31) . In kidneys, A 3 R has been detected both on mRNA and protein levels in various species (7, 22, 23, 26, 30) . However, the location and function of the A 3 R in the kidney are poorly characterized. The objective of the present study is to identify whether A 3 R is expressed in the afferent arterioles (Af-Art), which are the most important resistant vessels in the kidney (6) , and its role in regulating the tone of the Af-Art.
METHODS
Animals. Experiments were conducted on male 8-to 12-wk-old C57BL/6J mice. All experiments were preapproved by the Animal Care and Use Committees of University of Mississippi Medical Center and University of South Florida.
Expression of adenosine receptors in microdissected Af-Art using RT-PCR and real-time PCR.
An individual Af-Art with attached glomerulus was dissected as previously described (24) , and then cut between interlobular artery and glomerulus to get a clean Af-Art. Fifteen to twenty arterioles were microdissected in ice-cold MEM within 40 min from a mouse and transferred into RLT buffer (RNeasy Micro Kit, Qiagen) for total RNA extraction.
For RT-PCR measurement, total RNA was extracted with TRIzol (Invitrogen) according to the manufacturer's instructions. Sequences of A3R primers were 5´-CGGGATCCCGTTCCGTGGTCAGTTTG-3´; 5´-GGAATTCGCAGGCGTAGACAATAGG-3´. ␤-Actin was used to serve as a housekeeping gene. After qualification of the cDNA templates and primers, PCR was performed in a thermal cycler (Bio-Rad, Hercules, CA). Negative controls were performed by omitting cDNA template from the PCR amplification. The mixed samples were heated to 95°C for 5 min and then cycled for 40 cycles at 94°C for 30 s, 60°C for 20 s, 72°C for 30 s. Final extension was 8 min at 72°C. PCR products were electrophoresed on a 1.5% agarose gel and stained with ethidium bromide. Images were captured using a VersaDoc image analysis system (Bio-Rad).
For real-time PCR measurement, the first-strand cDNA was synthesized with reverse transcription system (Promega). The specific primers were the same as published by Vitzthum et al. (37) : A1:  5=-CGGG ATCC TACA TCTC GGCC TTCC AGG-3=; 5=-GGAA  TTCA GTAG GTCT GTGG CCCA ATG-3=, A2A: 5=-CGGG ATCC  GTCC CTGG CCAT CATC GT-3=; 5=-GGAA TTCG ATCC TGTA  GGCG TAGAT-3=, A2B: 5=-CGGG ATCC TTTC ACGG CTGC  CTCT TC-3=; 5=-GGAATTCCATCCCCCAGTTCTGTGC-3=, A3: 5=-CGGG ATCC CGTT CCGT GGTC AGTT TG-3=; 5=-GGAA TTCG CAGG CGTA GACA ATAGG-3=. ␤-Actin was used as a housekeeping gene. Quantitative PCR analysis was performed using iQ SYBR Green Supermix (Bio-Rad) and CFX96 Real-Time Detection System (Bio-Rad).
A3R agonist-induced vascular response of Af-Art. The microisolation and perfusion of the Af-Art were similar as described previously (24) . Briefly, the mice were anesthetized with ketamine and xylazine. Kidneys were removed and sliced along the corticomedullary axis immediately after euthanization and placed in 4°C minimum essential medium (MEM; Gibco, Grand Island, NY) containing 5% bovine serum albumin (BSA; Sigma, St. Louis, MO). Af-Art with attached glomerulus was microdissected under a stereomicroscope (SMZ 1500, Nikon) and then transferred to a temperature-controlled chamber on the stage of an inverted microscope (Eclipse Ti, Nikon), and perfused using a micromanipulator system with concentric holding and perfusion pipettes. Microdissections and perfusions were completed within 40 min at 4°C. The bath consisted of MEM and was exchanged continuously at a rate of 1 ml/min at 37°C. The perfusion pressure of the Af-Art was maintained at 60 mmHg during experiment. Once the temperature was stable, a 30-min equilibration period was allowed before any measurements were taken. The imaging system consisted of a microscope (Eclipse Ti, Nikon), digital CCD camera (CoolSnap, Photometrics), xenon light (LB-LS/30, Shutter Instruments), and optical filter changer (Lambda 10-3, Shutter Instruments). Images were displayed and analyzed with NIS-Elements imaging software (Nikon).
To study the potential role of A 3R in modifying vascular responsiveness, we first examined the vasoconstrictor response of Af-Art in response to A 3R agonists. The diameter of Af-Art was measured in the MEM perfusion solution. Then, A3R agonist was added and the diameter of the Af-Art was measured again 15 min later. To test the vasodilatory response, the Af-Art was preconstricted with norepinephrine (NE) and two different A 3R agonists,
were added to the bath, respectively, in the presence of NE and 15 min later the diameter of the Af-Art was again recorded. The 2-CL-IB-MECA compound is a high-affinity and selective A 3R agonist (Ki ϭ 0.33 nmol/l). It displays 2,500-fold selectivity over A1 and 1,400-fold selectivity over A2A receptors, respectively.
Interaction of A1R and A2R with A3R. To study the interaction of A3R and A1R, the dose-response curve of A1R mimetic N 6 -cyclohexyladenosine (CHA) was first measured and then compared with the presence of A3R agonist IB-MECA.
To test whether the A3R agonist is also stimulating A2R, the Af-Art was preconstricted with NE, and then an A2 antagonist,
, was added to the bath for 15 min, followed by adding A 3R agonist IB-MECA. The concentration used for ZM241385 (10 Ϫ7 mol/l) is considered to inhibit both A2A and A2B receptors (18) . To ensure that the vascular dilation effect of A3R agonist was through activation of A3R and not through A2R, additional series of experiments were performed. A selective A3R antagonist, 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(Ϯ)-dihydropyridine-3,5-dicarboxylate (MRS 1191), was added to the bath for 15 min in the presence of NE, followed by adding A 3R agonist IB-MECA.
Interaction of ANG II with A3R. To determine the effect of A3R agonist on ANG II-induced renal vasoconstriction, we compared the vasoconstrictor response of Af-Art to ANG II with and without the presence of an A 3R agonist IB-MECA.
Statistics. Data were analyzed as repeated measures when multiple samples were compared with common control. Data are presented as means Ϯ SE. The significance of differences in control and experimental values within the same animal was determined by a paired t-test. The significance of differences in corresponding mean values between groups was determined by ANOVA followed by Holm-Sidak test. P Ͻ 0.05 was considered as statistically significant changes.
RESULTS
Adenosine A 3 receptors are expressed in Af-Art. We first tested whether adenosine A 3 R was expressed in the Af-Art by RT-PCR. As shown in Fig. 1A , A 3 R was expressed in Af-Art. Then, we compared the expression level of A 3 R with other adenosine receptors using real-time PCR. All adenosine subtype receptors were present in Af-Art as shown in Fig. 1B , where mRNA levels of A 2A , A 2B , and A 3 were 44, 113, and 59%, respectively, compared with A 1 R (n ϭ 5 mice).
Activation of A 3 R dilates Af-Art. To test whether activation of the A 3 R constricts the Af-Art, we used a selective A 3 R agonist IB-MECA. At basal condition when the Af-Art was perfused with MEM, the diameter of the Af-Art was 10.4 Ϯ 0.1 m. Then, we added different doses of IB-MECA to the bath for 15 min, respectively. As shown in Fig. 2 , IB-MECA from 
10
Ϫ7 to 10 Ϫ4 mol/l did not significantly change the diameter of the Af-Arts, indicating that activation of the A 3 R did not constrict the Af-Art (n ϭ 9).
To test whether activation of the A 3 R dilates the Af-Art, we examined the effect of A 3 R agonist on preconstricted Af-Art. We preconstricted the Af-Art by ϳ20% with NE in the bath (10 Ϫ6 to 10 Ϫ7 mol/l; depends on the response of Af-Art). As shown in Fig. 3A , the Af-Arts were constricted from 11.1 Ϯ 0.2 to 9.5 Ϯ 0.2 m following application of NE. Then, we added A 3 R agonist IB-MECA at the concentration of 10 Ϫ4 mol/l in the bath in the presence of NE. The Af-Art dilated to 11.1 Ϯ 0.6 m (n ϭ 8). All the effects occurred within 5 min after IB-MECA administration.
To further confirm this effect, we used another more selective A 3 R agonist 2-CL-IB-MECA and repeated the above experiments as shown in Fig. 3B . The Af-Arts were preconstricted from 11. Vehicle alone had no constriction or dilatory effect on preconstricted Af-Art. These data indicate that activating the A 3 R causes acute vasodilation of the Af-Art.
Activation of the A 3 R counteracts ANG II-and A 1 R-mediated contraction of the Af-Art. Activation of A 1 R is known to constrict Af-Art. We tested whether simultaneous activation of A 3 R influenced the constrictive effect of A 1 R activation. We used the selective A 1 R agonist CHA and found that CHA constricted Af-Arts in a dose-dependent manner. The diameters of the Af-Arts were 10.
Ϫ9 to 10 Ϫ4 mol/l (n ϭ 7). In separate experiments, we first pretreated the Af-Art with A 3 R agonist IB-MECA for 15 min and repeated the CHA dose-response experiments in the presence of the IB-MECA. As shown in Fig. 4 , activation of A 3 R with IB-MECA inhibited the constrictive effect of A 1 R on the Af-Art (n ϭ 5). These data further supported that activation of A 3 R dilates the Af-Art.
We then studied whether A 3 R-induced dilation counteracts the ANG II-induced constriction. As shown in Dilatory effect of A 3 R activation is mediated through the A 3 R, not the A 2 R. Since the activation of adenosine A 2 R also causes vasodilation, we tested whether the A 3 R agonist was activating the A 2 receptor and dilated the Af-Art, rather than (Fig. 6A, n ϭ 6 ), indicating that the dilatory effect of A 3 R agonist was not mediated by activation of A 2A or A 2B receptors.
To further test the role of A 3 R activation on the tone of the Af-Art, we repeated the protocol and used a selective A 3 R antagonist MRS 1191. As shown in Fig. 6B , we first preconstricted the Af-Arts from 10. (Fig. 6B, n ϭ 5) . These data further demonstrated that the dilatory effect of A 3 R agonist on the Af-Art is mediated by activation of A 3 R.
DISCUSSION
In the present study, we found that adenosine A 3 R is expressed in mouse Af-Arts, while the expressions of A 1 and A 2B receptor mRNAs are predominant. Activation of the A 3 receptor dilates the Af-Art.
Adenosine is an endogenous purine nucleoside that modulates many physiological processes. Cellular signaling by adenosine occurs through four known adenosine receptor subtypes (A 1 , A 2A , A 2B , and A 3 ) (10, 11, 25) . In the renal vasculature, A 1 , A 2A , and A 2B receptors have been found in the preglomerular microvessels (16) . However, A 3 R expression failed to detect from several tubular segments including the following: proximal tubule, outer medullary descending thin limb of Henle's loop, inner medullary descending and ascending thin limb, thick ascending limb of Henle's loop, distal convoluted tubule, connecting tubule, cortical collecting duct, and outer medullary and inner medullary collecting duct (12, 16, 37-39) . As we know, there is no study yet to examine the expression of adenosine receptors specifically in the Af-Arts. In the present study, we dissected ϳ20 Af-Arts from each mouse to extract RNA for a RT-PCR and real-time PCR measurement. We found a clear band of A 3 R mRNA expression. The A 3 R mRNA level was ϳ59% of A 1 R, while A 2B R mRNA level was highest at ϳ114%, and A 2A R mRNA level was the lowest at ϳ45% of A 1 R in the Af-Arts. In isolated preglomerular microvessels isolated with an iron oxide-sieving technique (3, 16, 19) , high expressions of A 1 R and A 2B R were found, with lower expressions of A 2A R, which were similar to our findings; however, A 3 R was very low or not detectable both at mRNA and protein levels (16) . These preglomerular microvessels were mainly interlobular arteries and Af-Arts. Therefore, it is possible that A 3 R are exclusively expressed in the Af-Arts, while A 1 R and A 2B R are widely expressed along the preglomerular vessels. Further studies need to be done by comparing the expression levels of adenosine receptors between Af-Arts and interlobular arteries. The microdissection and isolation technique are very specific for Af-Art, but the amount of sample is very limited. Therefore, it is difficult to measure protein levels using this method.
Adenosine induces biphasic effects with vasoconstriction via A 1 R and vasodilation via A 2 R on the Af-Arts (8, 14) . However, the function of A 3 R in regulation of the Af-Art vasculature tone is unknown. In this study, we approached this question by using selective adenosine receptor agonists and antagonists.
We first examined whether A 3 R activation constricts the Af-Art. We used a selective A 3 R agonist IB-MECA and did not find alterations in the diameter of perfused Af-Art, suggesting no vasoconstrictive effect of A 3 R activation. Next, we measured whether activation of the A 3 R dilates the Af-Art. Since the basal vascular tone in isolated perfused Af-Art is very weak, the vessels need to be preconstricted to examine the dilatory effect. We found that activation of A 3 R dilated the preconstricted Af-Art, indicating that A 3 R has a vasodilatory effect. The studies regarding the functions of A 3 R are limited. Even though activation of A 3 R has been reported to have an anti-inflammatory effect (13, 17, 35) , there is very little information regarding the functional role of A 3 R in the vasculature. Stimulation of A 3 R has been reported to decrease blood pressure in ANG II-treated rats (9) and A 3 R activation has been found to be protective for renal ischemia injury (21) . However, whether and how the vasodilatory effect of A 3 R on the Af-Art that was demonstrated in this study may contribute to these situations need to be ascertained in future studies.
To study the interaction between adenosine A 1 and A 3 receptor activation on the Af-Art, we examined the effect of A 3 R agonist IB-MECA on the Af-Art constricted by selective A 1 R agonist CHA. We found that the A 3 R agonist IB-MECA inhibited the constrictive effect induced by A 1 R agonist CHA. Then, we examined the effect of activation of A 3 R on the Af-Art constricted by ANG II. We found A 3 R agonist IB-MECA blocked the effect of ANG II on the Af-Art. These data also supported that activation of A 3 R dilates the Af-Art, thereby counteracting the constrictive effect of A 1 R agonist and ANG II. However, we cannot exclude the possibility whether A 3 R has any direct interaction with A 1 R or ANG II AT 1 receptor. We are aware that we used a high concentration of A 3 R agonist IB-MECA to see the maximum effect of A 3 R activation. However, the observed effect in the present study that A 3 R activation blocked the constrictive effect of A 1 R activation and ANG II may not be a physiological phenomenon. In addition, high concentration of IB-MECA may not be selective anymore and may activate adenosine A 2 receptors.
To determine whether A 3 R agonist dilated the Af-Arts by stimulating A 2 receptors, we examined the effect of the A 3 R agonist in the presence of either the selective A 2 receptor antagonist or the selective A 3 R antagonist. ZM241385 is a potent and highly selective adenosine A 2 antagonist and is active in vivo. It has binding affinities of 540, 1.4, 31, and 270 nM for human A 1 , A 2A , A 2B , A 3 receptors, respectively, and shows selectivity of 1,000, 91, and 500,000 over A 1 , A 2B , and A 3 sites (18) . Thus, the dose of ZM241385 used in the present study (i.e., 10
Ϫ7 mol/l) should efficiently block both A 2A and A 2B receptors, and not affect the activity of A 1 and A 3 receptors. We found that inhibition of A 2 R had no effect on the dilatory effect on the Af-Art induced by A 3 R agonist. However, A 3 R antagonist totally blocked dilatory effect on the Af-Art induced by A 3 R agonist. Our data indicated that the vasodilatory effect of the A 3 R agonist was mediated by activation of A 3 R, not A 2 R.
Adenosine has been proposed to mediate tubuloglomerular feedback (TGF) via activation of the adenosine A 1 R. At the same time, activation of adenosine A 2 R has been demonstrated to attenuate the TGF response (29, 33) . The dilatation effect of A 3 R may also contribute to the regulation of TGF responsiveness. The significance of A 3 R in the Af-Arts in control of TGF and renal hemodynamics needs to be further investigated.
In conclusion, we found that adenosine A 3 R is expressed in the Af-Art and activation of A 3 R is associated with a vasodilatory effect. The conclusion regarding the functional role of A 3 receptor in this study is limited by its pharmacological approach and future studies using transgenic mice are warranted. Future studies are also aimed to determine the in vivo effects of A 3 receptor signaling on renal and cardiovascular function in health and diseases.
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